A nationwide registry study from the meticulous data vaults of FinSpine register set out to answer a question every spine surgeon wonders but rarely tracks: what actually happens to opioid and neuropathic pain medication use after ACDF for degenerative cervical spine disease?
Not what patients say. Not what surgeons hope. What they actually purchase.
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
